MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Biomet sees slight sales increase as losses widen
Biomet Inc. reported losses of $11.6 million on sales of $678.0 million during the three months ended Feb. 28. That compares with losses $3.1 million on sales of $669.8 million during the same period ending February 28, 2010.
Read more
Spine Pain Management jumps out of the red
Spine Pain Management Inc. (OTC:SPIN) reported losses of $1.1 million, or 6 cents per diluted share, on sales of $3.4 million for the year ended Dec. 31, 2010. That compares with losses of $720,526, or 5 cents per share, on sales of $540,505 in 2009.
Read more
Streamline Health Solutions flows into the red
Streamline Health Solutions Inc. (NSDQ:STRM) reported losses of $1.8 million, or 19 cents per diluted share, on sales of $4.9 million during the three months ended Jan. 31, 2011. That compares with profits of $1.6 million , or 17 cents per diluted share, on revenues of $6.3 million during the same period in 2009.
Full-year losses were $3.0 million, or 31 cents per share, on sales of $17.6 million. That compares with profits of $1.3 million, or 14 cents per share, on sales sales of $18.2 million in 2009.
Read more
BSD Medical sales fall dramatically
BSD Medical Corp. (NSDQ:BSDM) reported losses of $1.6 million, or 5 cents per diluted share, on sales of $444.4 million for the three months ended Feb. 28. That compares with losses of $1.9 million, or 9 cents per diluted share, on sales of $600.1 million for the same period in 2009.
Read more
PhotoMedex Inc. sales jump 27 percent, breaking $10 million
PhotoMedex Inc. (NSDQ:PHMD) reported losses of $1.8 million, or 65 cents per diluted share, on sales of $10.5 million during the three months ended Dec. 31, 2010. That compares with losses of $2.3 million, or $1.12 per diluted share, on sales of $8.3 million during the same period in 2009.
Full-year losses were $8.7 million, or $3.37 per diluted share, on sales of $34.8 million. That compares with losses of $10.5 million, or $6.42 per diluted share, on sales of $32.7 million in 2009.
Read more
AngioDynamics sales, profits continue rise
AngioDynamics Inc. (NSDQ:ANGO) posted net income of $3.8 million, or 15 cents per diluted share, on sales of $54.6 million during the three months ended Feb. 28. That compares with net income of $3.3 million, or 13 cents per diluted share, on sales of $52.2 million during the same period last year.
Read more
Medicrea losses ease as sales jump
Medicrea Group (Paris:ALMED) reported losses of €2.5 million on sales of €18.2 million during the year ended Dec. 31. That compares with a loss of €2.8 million on sales of €13.8 million in 2009.
Read more
Milestone Scientific earnings climb 14 percent
Milestone Scientific Inc. (OTC:MLSS) reported a loss of $614,508, or 4 cents per diluted share, on sales of $9.7 million during the year ended Dec. 31. That compares with a loss of $1.5 million, or 11 cents per diluted share, on sales of $8.5 million during 2009.
Read more
